Clinical Trial: Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment
Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment
Brief Summary: Helicobacter pylori (H. pylori), which infects about 50% of the global population, has been recognized as a main risk factor of multiple gastric pathologies, especially non-cardiac gastric cancer. Strongly evidence supports that H. pylori eradication is an effective approach to reduce the incidence of those pathologies.
Detailed Summary:
Sponsor: Yanqing Li
Current Primary Outcome: Eradication rate of AST guided triple therapy [ Time Frame: 3 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- the rate of improving dyspepsia symptoms after H. pylori eradication [ Time Frame: 3 months ]
- the rate of adverse events happening [ Time Frame: 3 months ]
- the rate of good compliance (take pills more than 90%) [ Time Frame: 3 months ]
Original Secondary Outcome: Same as current
Information By: Shandong University
Dates:
Date Received: April 23, 2017
Date Started: May 30, 2017
Date Completion: June 30, 2017
Last Updated: May 2, 2017
Last Verified: May 2017
